| Financial Year |
March 31 2023 |
| Monetary Funds |
1,048,661,835.59 |
| Held-for-trading Financial Assets |
16,136,892.91 |
| Notes Receivable |
-- |
| Accounts Receivable |
28,218,106.67 |
| Advances to Suppliers |
4,051,989.60 |
| Other Receivables |
12,868,658.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
47,042,367.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,111,795.56 |
| Total Current Assets |
1,161,161,203.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,926,551.85 |
| Investment Properties |
1,142,219.85 |
| Fixed Assetes |
1,454,285,025.75 |
| Under-construction Projects |
89,772,870.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
388,770,470.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,215,817.45 |
| Deferred Income Tax Assets |
14,859,513.46 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,999,619,614.17 |
| Total Assets |
3,160,780,817.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
30,371,652.76 |
| Accounts Received In Advance |
317,750.88 |
| Employee Compensation Payable |
46,114,427.58 |
| Taxes Payable |
2,191,847.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,331,368.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,567,208.38 |
| Other Current Liabilities |
2,355,151.21 |
| Sub-Total of Current Liabilities |
243,599,396.62 |
| Long-term Loans |
494,525,395.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,091,216.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
545,132,503.85 |
| Total Liabilities |
788,731,900.47 |
| Paid-In Capital(Or Share Stock) |
526,913,102.00 |
| Capital Surplus |
404,762,083.74 |
| Surplus Reserve |
241,385,497.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,159,540,709.89 |
| Minority Stockholder's Interest |
39,447,524.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,332,601,392.82 |
| Owner's Equity（Stockholder's Equity） |
2,372,048,917.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,160,780,817.87 |
